Janus kinase inhibition suppresses PKC-induced cytokine release without affecting HIV-1 latency reversal ex vivo.
Adam M SpivakErin T LarragoiteMcKenna L ColettiAmanda B MacedoLaura J MartinsAlberto BosqueVicente PlanellesPublished in: Retrovirology (2016)
The combination of ingenol compounds and JAK inhibition represents a novel strategy for HIV-1 eradication.